Clinical utility of patiromer, sodium zirconium cyclosilicate, and sodium polystyrene sulfonate for the treatment of hyperkalemia: an evidence-based review

INTRODUCTION: Hyperkalemia is a serious medical condition that often manifests in patients with chronic kidney disease and heart failure. Renin–angiotensin–aldosterone system inhibitors are known to improve outcomes in these disease states but can also cause drug-induced hyperkalemia. New therapeuti...

Descripción completa

Detalles Bibliográficos
Autores principales: Beccari, Mario V, Meaney, Calvin J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367739/
https://www.ncbi.nlm.nih.gov/pubmed/28356904
http://dx.doi.org/10.2147/CE.S129555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367739/
https://www.ncbi.nlm.nih.gov/pubmed/28356904
http://dx.doi.org/10.2147/CE.S129555

Ejemplares similares